Posted 2 October 2007
Important Notice: Alzheimer Research Forum does not provide
medical advice nor promote any product or service. The contents are for informational
purposes only and are not intended to substitute for professional medical advice,
diagnosis or treatment. Always seek advice from a qualified physician or health
care professional about any medical concern, and do not disregard professional medical
advice because of anything you may read on this web site. The views of individuals
quoted on this site are not necessarily those of the Alzheimer Research Forum.
Massachusetts General Hospital, Boston
This institution has an ongoing eFAD imaging study that aims to understand how the appearance of amyloid relates to changes in brain function. The study welcomes carriers of eFAD mutations and their unaffected siblings. It tracks the earliest evidence of amyloid deposition in asymptomatic carriers years before symptoms are expected, and looks for evidence of any brain dysfunction during that time. In some instances, the work has been performed in collaboration with other research centers. The goals of the study include improved understanding of amyloid as a target for future preventive treatment.
Keith A. Johnson, M.D.
Massachusetts General Hospital
55 Fruit St
Boston, MA 02114
Reisa Sperling, M.D., M.MSc.
Brigham and Women's Hospital
221 Longwood Avenue
Boston, MA 02115
- A PIB-PET scan, an FDG-PET scan, structural and functional MRI.
- Neuropsychological testing.
- Clinical assessment.
Limited reimbursement available to offset travel and lodging expenses.